(4-Oxo-2,3-dihydro-1H,4H-8-thia-5,7-diaza-cyclopenta[a]inden-5-yl)-acetic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)

(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide (Linagliptin Impurity), 97%, 50mg

Tributylhexylphosphonium Bromide>98.0%(T)5g

2-Methoxy-3-methyl-benzoic acid, 95.0%, 1g

(4S,5R)-2-(6-METHYLPYRIDIN-2-YL)-4,5-DIPHENYL-4,5-DIHYDROOXAZOLE, 95%, 1g

Diethyl (N-Methoxy-N-methylcarbamoylmethyl)phosphonate>97.0%(GC)1g

Dimethyldioctadecylammonium chloride, 98.0%, 100g

1-(4-morpholinyl)acetone, 95.0%, 10g

tert-butyl N-[(4-aminotetrahydrothiopyran-4-yl)methyl]carbamate, 97, 100mg

(Acryloxypropyl)methylsiloxane-dimethylsiloxane co-polymer cSt 80-120, 100g

Cryogenic vials True North sterile, colourless, 500 Piece(s)

Safety glasses pheos cx2, red, gray, 9198-258, 1 Piece